Free Trial

Aspen Aerogels, Inc. (NYSE:ASPN) Receives $18.44 Average PT from Brokerages

Aspen Aerogels logo with Construction background

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) has earned an average rating of "Moderate Buy" from the eleven brokerages that are currently covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $18.44.

Several analysts have recently commented on ASPN shares. Oppenheimer downgraded Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. Barclays reissued an "equal weight" rating and issued a $7.00 price target (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. Finally, TD Cowen raised Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th.

View Our Latest Analysis on ASPN

Insider Activity

In related news, CEO Donald R. Young acquired 20,000 shares of the firm's stock in a transaction that occurred on Monday, May 12th. The stock was acquired at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the completion of the acquisition, the chief executive officer now owns 550,856 shares of the company's stock, valued at approximately $2,947,079.60. This represents a 3.77% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 4.30% of the company's stock.

Institutional Investors Weigh In On Aspen Aerogels

Several large investors have recently modified their holdings of the stock. Acadian Asset Management LLC purchased a new stake in Aspen Aerogels in the first quarter worth $43,000. Palogic Value Management L.P. increased its position in Aspen Aerogels by 226.9% in the first quarter. Palogic Value Management L.P. now owns 425,000 shares of the construction company's stock worth $2,716,000 after buying an additional 295,000 shares during the last quarter. Caxton Associates LLP purchased a new stake in Aspen Aerogels in the 1st quarter worth about $307,000. Voleon Capital Management LP purchased a new stake in Aspen Aerogels in the 1st quarter worth about $282,000. Finally, Goldman Sachs Group Inc. increased its holdings in Aspen Aerogels by 89.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company's stock worth $8,143,000 after acquiring an additional 602,586 shares during the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Aspen Aerogels Stock Down 2.1%

ASPN stock traded down $0.13 during trading on Thursday, reaching $5.80. 2,208,735 shares of the stock were exchanged, compared to its average volume of 2,008,699. The firm's 50 day moving average is $5.78 and its 200 day moving average is $8.44. Aspen Aerogels has a twelve month low of $4.16 and a twelve month high of $33.15. The company has a current ratio of 4.22, a quick ratio of 3.53 and a debt-to-equity ratio of 0.40. The firm has a market cap of $475.80 million, a P/E ratio of -1.66 and a beta of 2.68.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Aspen Aerogels had a negative net margin of 65.47% and a positive return on equity of 6.69%. The company had revenue of $78.72 million for the quarter, compared to analyst estimates of $82.75 million. During the same quarter in the prior year, the business posted ($0.02) EPS. The firm's revenue was down 16.7% compared to the same quarter last year. As a group, research analysts forecast that Aspen Aerogels will post 0.17 EPS for the current year.

Aspen Aerogels Company Profile

(Get Free Report

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Recommended Stories

Analyst Recommendations for Aspen Aerogels (NYSE:ASPN)

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines